Skip to main content
. Author manuscript; available in PMC: 2022 Jun 18.
Published in final edited form as: Toxicol Lett. 2021 Jan 6;340:33–42. doi: 10.1016/j.toxlet.2021.01.005

Fig. 3.

Fig. 3.

Acrolein exposure reduced glutathione (GSH) and glutathione peroxidase 4 (GPx4) levels in hCSFs. MTT cell viability assay showed the dose-dependent response of buthionine sulphoximine (BSO), a glutathione inhibitor (A) in hCSFs. Exposure to acrolein (ACR) significantly compromised GSH levels, which was further decreased in the presence of BSO (B). Quantitative RT-PCR data depicted that ACR exposure compromised the GPx4 level, which remained unchanged in the presence of BSO, (C). All the experiments were independently performed three times using each sample in triplicates. The results were presented as mean ± SEM. The one-way analysis of variance (ANOVA) with Bonferroni post hoc test were used for statistical analysis. **p ≤ 0.01, ***p ≤ 0.001 compared to CTL group and ##p ≤ 0.01 compared to the ACR group.